von Mehren M, Randall RL, Benjamin RS, et al (2018) Soft tissue sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw16:536–563
Sbaraglia M, Bellan E, Dei Tos AP (2021) The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica 113:70–84
Demetri GD, Baker LH, Beech D et al (2005) Soft tissue sarcoma clinical practice guidelines in oncology. J Natl Compr Canc Netw 3:158–194
PubMed PubMed Central Google Scholar
Szurian K, Kashofer K, Liegl-Atzwanger B (2017) Role of next-generation sequencing as a diagnostic tool for the evaluation of bone and soft-tissue tumors. Pathobiology 84:323–338
de Alava E (2017) Ewing sarcoma, an update on molecular pathology with therapeutic implications. Surg Pathol Clin 10:575–585
Arnold MA, Barr FG (2017) Molecular diagnostics in the management of rhabdomyosarcoma. Expert Rev Mol Diagn 17:189–194
Article PubMed PubMed Central Google Scholar
ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25:iii102–12
Tian Z, Yao W (2023) Chemotherapeutic drugs for soft tissue sarcomas: a review. Front Pharmacol 14:1199292
Article PubMed PubMed Central Google Scholar
Kyriazoglou A, Gkaralea LE, Kotsantis I et al (2022) Tyrosine kinase inhibitors in sarcoma treatment. Oncol Lett 23:183
Article PubMed PubMed Central Google Scholar
Tang F, Tie Y, Wei YQ et al (2021) Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Biochim Biophys Acta Rev Cancer 1876:188606
Nakano K, Takahashi S (2020) Precision medicine in soft tissue sarcoma treatment. Cancers (Basel) 12:221
Gounder MM, Agaram NP, Trabucco SE et al (2022) Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma. Nat Commun 13:3406
Article PubMed PubMed Central Google Scholar
Chen S, Zhou Y, Chen Y et al (2018) fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884–i890
Article PubMed PubMed Central Google Scholar
Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754–1760
Article PubMed PubMed Central Google Scholar
Lai Z, Markovets A, Ahdesmaki M et al (2016) VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res 44:e108
Article PubMed PubMed Central Google Scholar
Li Q, Wang K (2017) InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet 100:267–280
Article PubMed PubMed Central Google Scholar
Talevich E, Shain AH, Botton T et al (2016) CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol 12:e1004873
Article PubMed PubMed Central Google Scholar
Newman AM, Bratman SV, Stehr H et al (2014) FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics 30:3390–3393
Article PubMed PubMed Central Google Scholar
FDA Recognition of Public Human Genetic Variant Databases. (Official FDA website, 2024) or MSK's Precision Oncology Knowledge Base
Drilon A, Laetsch TW, Kummar S et al (2018) Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med 378:731–739
Article PubMed PubMed Central Google Scholar
Hasegawa N, Hayashi T, Niizuma H et al (2024) Detection of novel tyrosine kinase fusion genes as potential therapeutic targets in bone and soft tissue sarcomas using DNA/RNA-based clinical sequencing. Clin Orthop Relat Res 482(3):549–563
Jin G, Wang C, Jia D et al (2021) Next generation sequencing reveals pathogenic and actionable genetic alterations of soft tissue sarcoma in Chinese patients: a single center experience. Technol Cancer Res Treat 20:15330338211068964
Article PubMed PubMed Central Google Scholar
Gan M, Zhang C, Qiu L et al (2022) Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients. Cancer Med 11:4070–4078
Article PubMed PubMed Central Google Scholar
Zhang Q, Yang Y, You X et al (2023) Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas. Front Oncol 13:1173275
Article PubMed PubMed Central Google Scholar
Sharpless NE (2005) INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 576:22–38
Nakano K, Takahashi S (2020) Precision medicine in soft tissue sarcoma treatment. Cancers (Basel) 12:221
Delattre O, Zucman J, Melot T et al (1994) The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294–299
Riggi N, Cironi L, Suvà ML, et al (2007) Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol 213:4–20
Riggi N, Cironi L, Provero P et al (2005) Development of Ewing’s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65:11459–11468
Riggi N, Suvà ML, Suvà D et al (2008) EWS-FLI-1 expression triggers a Ewing’s sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res 68:2176–2185
Ladanyi M, Antonescu CR, Leung DH et al (2002) Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 62:135–140
McBride MJ, Pulice JL, Beird HC et al (2018) The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma. Cancer Cell 33:1128-1141.e7
Article PubMed PubMed Central Google Scholar
Nielsen TO, Poulin NM, Ladanyi M (2015) Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy. Cancer Discov 5:124–134
Article PubMed PubMed Central Google Scholar
Koboldt DC (2020) Best practices for variant calling in clinical sequencing. Genome Med 12(1):91
Article PubMed PubMed Central Google Scholar
van Belzen IAEM, Schönhuth A, Kemmeren P, Hehir-Kwa JY (2021) Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology. NPJ Precis Oncol 5(1):15
Article PubMed PubMed Central Google Scholar
Liu Z, Roberts R, Mercer TR, Xu J, Sedlazeck FJ, Tong W (2022) Towards accurate and reliable resolution of structural variants for clinical diagnosis [published correction appears in Genome Biol 23(1):198.
Benayed R, Offin M, Mullaney K et al (2019) High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden. Clin Cancer Res 25(15):4712–4722
Article PubMed PubMed Central Google Scholar
Cohen D, Hondelink LM, Solleveld-Westerink N et al (2020) Optimizing mutation and fusion detection in NSCLC by sequential DNA and RNA sequencing. J Thorac Oncol 15(6):1000–1014
留言 (0)